Do prenatal vitamins really help? new study aims to find out
NCT ID NCT05062044
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study followed 1,500 women in higher-income countries who chose to take multivitamins or folic acid before or during pregnancy. Researchers tracked pregnancy outcomes like full-term birth, anemia, preeclampsia, and baby birth weight. The goal is to gather real-world data on how vitamin supplements affect pregnancy health in these populations.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Multivitamins (Elevit)
- What this could lead to
- If successful, this study could provide better evidence on how vitamin supplements affect pregnancy outcomes in higher-income countries.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by other factors like diet and lifestyle.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,500 people
The number who actually took part.
- Started
-
Dec 2021
- Finished
-
Jul 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women aged 18 through 45 (inclusive) planning a pregnancy or with an already confirmed pregnancy (pregnancy was confirmed using laboratory and/or instrumental methods, pregnancy term is up to 12 weeks), of different risk of having micronutrient insufficiency and using Elevit Multiple Micronutrient (MMN) or a monocomponent supplementation with folic acid and being in compliance with the inclusion and exclusion criteria.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A woman aged 18 through 45 (inclusive) who is planning a pregnancy or with an already confirmed pregnancy with pregnancy term up to 12 weeks (pregnancy was confirmed by laboratory and/or ultrasound method). * Decision to use Elevit® MMN or monocomponent supplementation of folic acid was made independent of study participation, and made prior to inclusion into this study. * Provided signed Informed Consent to participate in the study * Ability to understand and follow study-related instructions. * Be willing and able to participate in all scheduled visits, treatment plan, laboratory tests and other trial procedures according to the study protocol and the standard medical practice. Exclusion Criteria: * Concurrent participation in interventional or other non-interventional study. * The gestation period is more than 12 weeks. * Taking any folate-containing products other than Elevit® for three months prior to enrollment in the study. * Usage of other than Elevit Multiple Micronutrient product. * Malignant neoplasms at present or in history. * History of pregnancy with congenital malformations. * Contraindications to the use of MMN Elevit specified in the approved instructions for use (for the medicinal product "Elevit® Pronatal") or leaflet (for dietary supplements "Elevit® planning and first trimester" and dietary supplements "Second and Third Trimester" of the trademark " Elevit®"). * Concomitant diseases in the stage of decompensation. * Multiple pregnancy diagnosed before enrollment. * Other pathological conditions that make it impossible for the subject to participate in the program (by the decision of the attending physician). * Member or first-degree relative of study staff or the Sponsor directly involved in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prevention of vitamin deficiency during and/or before pregnancy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Many Locations
Multiple Locations, Kazakhstan
-
Many Locations
Multiple Locations, Russia
-
Many Locations
Multiple Locations, Uzbekistan